Clatot, Florian

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor. [electronic resource] - Oncotarget 11 2016 - 74448-74459 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.12950 doi


Aromatase Inhibitors--therapeutic use
Biomarkers, Tumor
Breast Neoplasms--diagnosis
DNA, Neoplasm
Disease Progression
Estrogen Receptor alpha--genetics
Female
Follow-Up Studies
Humans
Mutation
Neoplasm Metastasis
Prognosis
Retrospective Studies
Risk Factors
Survival Analysis